Now let me finalize the review based on everything I've verified.

## Summary

This paper is a commentary/rebuttal responding to a published TPAMI response (Palazzo et al., 2024) that raised concerns about the authors' prior work (Bharadwaj et al., 2023; Ahmed et al., 2021). It argues that several claims in Palazzo et al. are false, misleading, unfounded, or invalid, supported by textual evidence from cited work and new empirical analyses. The paper addresses signal bleeding, subject attentiveness, session length, cross-subject variability, single-subject scope, supertrial frequency attenuation, and confound analyses.

## Strengths

- **Well-reasoned critique of the BDB blank-screen analysis (Section 8).** The paper correctly identifies that Palazzo et al. (2020b, Table 2) measures only *between-block* temporal correlation (training and test from different runs), not the *within-block* correlation (training and test from the same run) that drives the confound in Spampinato et al. (2017) and related work. Since Li et al. (2021) documented that the former produces weaker effects than the latter, this critique effectively undermines the main empirical defense of the block-design paradigm. This is the strongest logical argument in the paper.

- **New empirical analysis with frequency-domain supertrials (Section 7, Table 1).** The paper constructs supertrials via frequency-domain averaging and replicates the Bharadwaj et al. (2023) classification analysis across 8 classifiers and 11 supertrial sizes. The results show EEGChannelNet remains at chance while other classifiers (SVM, 1D CNN, EEGNet, SyncNet) achieve above-chance accuracy. This goes beyond textual argument and provides new evidence that the core finding is robust to the choice of averaging method.

- **Concrete factual correction (Section 4).** The paper documents a genuine inaccuracy: Spampinato et al. (2017, Table 1) states session length as 350 s (5 min 50 s), not "about 4 minutes" as claimed in Palazzo et al. (2024). This is a verifiable correction supported by the cited tables.

- **Clean rebuttal of the "designed to penalize" claim (Section 7).** The paper correctly notes that the supertrial method predates EEGChannelNet (Isik et al., 2014; Cichy et al., 2016; Greene & Hansen, 2020; Zheng et al., 2020a), so it could not have been designed to penalize a method that did not yet exist.

## Weaknesses

### Fatal

None.

### Major

- **Section 7 frames the frequency-domain averaging analysis as a refutation of Palazzo et al.'s claim, but this is a mismatch.** Palazzo et al.'s concern is about *time-domain* averaging of signals with inconsistent phase — a standard signal-processing fact. The paper tests *frequency-domain* averaging (FFT → average magnitude/phase separately → inverse FFT) and concludes the claim is "invalid" (line 160). Testing a different method does not refute a claim about the specific method that was used. The new analysis is *informative* — it shows the core result (EEGChannelNet at chance) holds even when the attenuation concern is sidestepped, which actually strengthens the original argument. However, the framing as a refutation is unsupported and overstated. The paper should either (a) acknowledge that time-domain averaging does have this attenuating effect and argue why it does not affect the classification conclusions, or (b) reframe the analysis as showing the result is robust to the choice of averaging method.

### Minor

- **Discrepancy between text and Figure 1 caption.** The text (line 152) states frequency-domain averaging "amplifies" higher-frequency components. However, the figure caption (lines 168–170) states: "All spectra show a general downward trend as frequency increases, with the raw trials having the highest power and the 100 supertrial size having the lowest power." If raw trials have the highest power across the spectrum and all supertrial supertrial sizes have lower power, this is attenuation, not amplification. The claim about amplification may refer to relative spectral shape (boost of high vs. low frequencies compared to time-domain averaging), but this is not explained, and the caption as written contradicts the textual claim.

- **Section 6 partially overstates its rebuttal.** Palazzo et al. state: "The dataset used by Bharadwaj et al., introduced in [7], is the result of EEG data collection on one subject only." This specific sentence about the Ahmed et al. (2021) dataset is factually true — it is a single-subject dataset. The paper calls this claim "false." The broader implication that the supertrial analysis was applied to only one subject is indeed incorrect (Bharadwaj et al. also analyzed six subjects from Li et al., 2021). The paper should distinguish between the dataset claim (true) and the analysis-scope claim (incorrect).

- **The ethics statement (lines 299–333) dramatically escalates the paper's scope beyond what the body demonstrates.** It asserts that "nearly one hundred published papers" are debunked, that the research community is knowingly "churn[ing] out a plethora of flawed results," and that the work causes medical harm to people with disabilities. The paper's body only addresses claims in a single response paper (Palazzo et al., 2024) about one dataset and one analysis. These sweeping claims are not supported by evidence presented in the paper and are inappropriate in a scientific rebuttal.

### Trivial

None.

## Nice-to-Haves

- **Empirical evidence for absence of signal bleeding (Sections 2–3).** The paper argues from experimental design parameters (2 s trials, 1 s blanking) that bleeding is unlikely. A stronger rebuttal could show that ERP components to the preceding trial have returned to baseline by the onset of the next trial in the actual data, but neither side in this debate provides direct empirical evidence on this point.
- **Further discussion of the single-subject limitation.** While the paper acknowledges that Ahmed et al. (2021) is a single-subject dataset and explains the resource tradeoff (lines 282–283), a fuller discussion of how this limits the generality of the conclusions would strengthen the paper.

## Removed Points

These points from the input review were removed with justification:

- **Section 5 being a "double-edged sword."** Removed: The observation that the paper's own randomized-trial results are at chance is not a genuine weakness — the paper acknowledges this and uses it to argue against cross-subject variability claims.
- **Section 7 bundling two rebuttals.** Removed (trivial): The two arguments (frequency attenuation and intent) are separated by a paragraph break in the same section. This is a presentation preference, not a substantive flaw.
- **Paper "does not address" the single-subject limitation.** Removed: The paper does address this at lines 282–283, explaining the resource tradeoff. Whether the addressal is sufficient is debatable, but the claim that it is absent is incorrect.
- **Section 2–3 lacking empirical evidence.** Removed (soft rule): The paper provides plausibility arguments from experimental parameters, which is reasonable for a rebuttal responding to specific criticisms. Requesting additional neural-level evidence is a nice-to-have, not a core weakness.

## Novel Insights

The most incisive observation is that the Section 7 frequency-domain analysis is misaligned with the claim it is framed to refute: Palazzo et al.'s concern is about time-domain averaging, but the paper tests frequency-domain averaging and declares the claim "invalid." This is a genuine evidential/rhetorical gap. However, once this framing is corrected, the analysis actually *strengthens* the paper's position by showing the result is robust to the choice of averaging method. Beyond this, the reviews do not surface insight beyond the paper's own contributions — the BDB critique, session-length correction, and designed-to-penalize rebuttal are all presented clearly by the paper itself.

## Suggestions

1. **Reframe Section 7.** Acknowledge that time-domain averaging does attenuate phase-inconsistent signals (standard signal processing). Then reposition the frequency-domain analysis as showing that (a) the supertrial method can be adapted to avoid this concern, and (b) even with this adaptation, the core finding (EEGChannelNet at chance) holds, demonstrating robustness. This turns an overclaimed refutation into a constructive strengthening.

2. **Resolve the Figure 1 caption–text discrepancy.** Clarify whether "amplifies" refers to absolute power or relative spectral shape, and ensure the caption is consistent with the textual claim.

3. **Scale back the ethics statement.** Either remove it or restrict it to claims directly supported by the paper's body. The current version makes unsupported broad accusations that undermine the tone of scientific precision.

4. **Refine Section 6.** Distinguish between the claim about the dataset (true — Ahmed et al., 2021 is single-subject) and the claim about the analysis (incorrect — six subjects from Li et al., 2021 were also analyzed).

## Calibration Anchors

| Path | Avg Score | Round | Itemized | Comparison |
|------|-----------|-------|----------|------------|
| nSDOkm0SKo.md | 1.00 | R1 bracket | No | Unrelated paper; score 1.0 suggests a fundamentally flawed/empty submission — not comparable |
| bEgDEyy2Yk.md | 1.00 | R1 | No | Dense graph algorithm implementation — unrelated topic and type |
| 8QTpYC4smR.md | 1.00 | R1 | No | LLM survey paper — unrelated |
| P49gSPmrvN.md | 1.00 | R1 | No | Discourse visualization — unrelated |
| n4SLaq5GhM.md | 3.25 | R1 | Yes | Position paper on medical NLP with no empirical validation — less comparable type |
| w2C7gJqaai.md | 2.33 | R1 | No | Prediction paradigm paper — unrelated |
| tKFZ53nerQ.md | 2.00 | R1 | No | Text generation — unrelated |
| SMKgohbroH.md | 3.00 | R1 | Yes | LLM consistency paper with significant methodological weaknesses — not a comparable type |
| GbEmJmnQCz.md | 4.40 | R1 | Yes | **Most comparable**: Critical re-analysis of a widely-cited paper (Feldman & Zhang 2020), identifying methodological errors. That paper had stronger strengths (+5.79 max) but also stronger weaknesses (-8.99 max) than the current paper. Our paper's strengths (+3.32) and weaknesses (-5.05) are both more moderate, placing it slightly below this anchor. |
| IULlNTZZel.md | 5.33 | R1 | No | LLM essay critique — unrelated topic |
| AAjCYWXC5I.md | 4.67 | R1 | Yes | Also comparable: paper about adversarial LLM interaction for research ideation — not a rebuttal per se but a critical methodology paper. Strengths (+5.31 max) stronger than ours; weaknesses (-7.66 max) also stronger. |
| lf8QQ2KMgv.md | 3.75 | R1 | Yes | Another version of the F&Z critical commentary (scored 3.75). Strengths (+4.16 max) and weaknesses (-7.13 max). Our paper's weakness profile (-5.05 max) is less severe, placing it slightly above this anchor. |
| dhLIno8FmH.md | 6.75 | R1 | Yes | Original EEG decoding research paper — very different paper type (novel method), not directly comparable for score anchoring |
| 4ltiMYgJo9.md | 5.75 | R1 | No | EEG visual stimulation paper — original research, not commentary |
| NPNUHgHF2w.md | 6.75 | R1 | No | EEG foundation model — original research |
| b57IG6N20B.md | 6.60 | R1 | No | Biosignal compression — original research |
| cNmu0hZ4CL.md | 8.00 | R1 | No | Neural population dynamics — high-quality original research |
| kbjJ9ZOakb.md | 8.00 | R1 | No | Visual cortex invariance — high-quality original research |
| Xo0Q1N7CGk.md | 8.00 | R1 | No | Grid cells theory — high-quality original research |
| aWXnKanInf.md | 8.00 | R1 | No | Topographic language model — high-quality original research |

**Bracket and calibration reasoning.** Round 1 bracketing placed the paper between 3.5 and 5.5, and the itemized comparison with the two most similar anchors (GbEmJmnQCz at 4.40 and lf8QQ2KMgv at 3.75 — both critical commentaries on published work) confirms this range. Our paper's strongest strength (BDB critique, +3.32) is weaker than the 4.40 anchor's strongest strength (+5.79) but comparable to the 3.75 anchor's (+4.16). Our strongest weakness (frequency-domain framing, -5.05) is substantially less severe than either anchor's strongest weakness (-8.99 and -7.13). On balance, the paper sits between these two anchors: its weaknesses are less damaging, but its strengths are also less impactful. The ethics statement overreach (-3.15) is a self-inflicted flaw that the comparable anchors did not have. The paper is a rebuttal/commentary rather than a novel-method paper, which limits its fit for ICLR's typical scope despite the genuine merit of its BDB critique and new empirical analysis. Final score: **4.0 (borderline reject)**.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>